Smartphone-Based Test and Predictive Models for Rapid, Non-Invasive, and Point-of-Care Monitoring of Ocular and Cardiovascular Complications Related to Diabetes

TL;DR

This paper presents a smartphone-based, non-invasive screening system using machine learning models to rapidly monitor diabetic retinopathy and cardiovascular risk, aiming to improve early detection and management especially in low-resource settings.

Contribution

The study introduces integrated machine learning models on a smartphone device with a 3D-printed retinal attachment for cost-effective, rapid diabetic complication screening.

Findings

Models achieved promising accuracy and ROC scores.

The system enables fast, inexpensive, point-of-care monitoring.

Potential to replace manual, costly diagnostic methods.

Abstract

Among the most impactful diabetic complications are diabetic retinopathy, the leading cause of blindness among working class adults, and cardiovascular disease, the leading cause of death worldwide. This study describes the development of improved machine learning based screening of these conditions. First, a random forest model was developed by retrospectively analyzing the influence of various risk factors (obtained quickly and non-invasively) on cardiovascular risk. Next, a deep-learning model was developed for prediction of diabetic retinopathy from retinal fundus images by a modified and re-trained InceptionV3 image classification model. The input was simplified by automatically segmenting the blood vessels in the retinal image. The technique of transfer learning enables the model to capitalize on existing infrastructure on the target device, meaning more versatile deployment, especially helpful in low-resource settings. The models were integrated into a smartphone-based device, combined with an inexpensive 3D-printed retinal imaging attachment. Accuracy scores, as well as the receiver operating characteristic curve, the learning curve, and other gauges, were promising. This test is much cheaper and faster, enabling continuous monitoring for two damaging complications of diabetes. It has the potential to replace the manual methods of diagnosing both diabetic retinopathy and cardiovascular risk, which are time consuming and costly processes only done by medical professionals away from the point of care, and to prevent irreversible blindness and heart-related complications through faster, cheaper, and safer monitoring of diabetic complications. As well, tracking of cardiovascular and ocular complications of diabetes can enable improved detection of other diabetic complications, leading to earlier and more efficient treatment on a global scale.